The Europe medical cannabis market was valued at USD 2.17 billion in 2023 and is projected to grow to USD 11.09 billion by 2032, with a CAGR of 19.3% from 2024 to 2032. This growth is driven by the expanding legalization and therapeutic uses of cannabis, as well as increasing patient demand. Additionally, advancements in cultivation and extraction technologies, strategic partnerships,... http://www.imarcgroup.com/europe-watch-market